Tilak Healthcare Appoints Bénigne Mathieu, MD Chief Business Officer

A seasoned expert in the pharmaceutical industry and the marketing of innovative health products

PARIS, September 15, 2022–(BUSINESS WIRE)–Tilak Healthcare, a pioneer in the development of mobile video games with medical modules for monitoring patients with chronic eye disease, announces the appointment of Dr. Benigne Mathieu as Chief Business Officer.

Good-natured Mathieu will ensure eligible patients can benefit from OdySight, the first serious games clinically validated, fully dedicated to remote monitoring of chronic vision diseases and reimbursed as part of an Article 51 experiment. It will also participate, in addition to of Edouard Gasser co-founder and CEOthe strategic development of Tilak Healthcare through the international commitment of OdySight to make it a major player in supporting patients with eye diseases.

Bénigne Mathieu is a doctor (Faculty of Medicine of Dijon) and holds a master’s degree in pharmaceutical marketing from ESCP, passionate about digital technologies applied to health. Over 14 years, he gradually evolved and held various strategic positions within Astra Zeneca before becoming director of the BU Cardiovascular, Kidney and Metabolism in 2019, where he led the marketing of flagship products. Bénigne started his professional career as a consultant and developer of medical websites, anticipating the necessary integration of digital technologies for the benefit of healthcare professionals.

The whole Tilak team is very happy to welcome Bénigne. His expertise in the pharmaceutical industry and market entry strategies for innovative health products, combined with his interest in digital sciences, is a significant asset to the development of our company. His arrival will strengthen Tilak Healthcare’s unique positioning in digital health and drive interest from prescribers, health decision-makers and investors. ” welcome Edouard Gasser, co-founder and CEO of Tilak Healthcare.

Good-natured Mathieu accurate: I am extremely proud to be part of the talented and visionary team at Tilak Healthcare, who have established themselves as the reference in the remote monitoring of vision diseases. This is an exceptional opportunity for me to combine my two passions: medicine and digital technologies. I look forward to promoting the potential of the technology developed by the management team, which successfully adapted the power of video games and entertainment to healthcare applications while revolutionizing patient care and medical practice. I am excited to be part of this (r)evolution through Tilak Healthcare’s innovations.”

About OdySight
OdySight is the first medical mobile video game for the remote monitoring of age-related vision diseases. It optimizes the care pathway for patients suffering from retinal pathologies such as AMD or diabetic retinopathy by allowing their ophthalmologists to monitor the evolution of their visual acuity in real time. Developed by a team of video game making experts and experienced scientists who are recognized worldwide, OdySight offers clinically validated medical tests and fun puzzles that promote patient use of the application to better care for their disease. Since March 2021, OdySight is reimbursed by the CNAM, under Article 51, an experimental device entitled ” Promote access to ophthalmic care with OdySight, a remote monitoring medical application that enables self-assessment of visual parameters. » More information: www.OdySight.app

About Tilak Healthcare
Tilak Healthcare is a company specializing in digital health, specifically developing a disruptive technology platform of medical video games, prescribed by health professionals, to support chronic diseases. Odysight, the first platform, focuses on ophthalmology, with chronic maculopathies, emerging pathologies and the leading cause of blindness in the world. It enables the improvement of patient care in the health trajectory. OdySight, the benchmark solution for home vision monitoring, is already present in the United States and Europe. The company originated in 2016 within the Ibionext ecosystem. For more information: www.tilakhealthcare.com

Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220915005626/en/


Contact Tilak Healthcare
Edouard Gasser: +33 (0)7 62 27 18 42 – egasser@tilakhealthcare.com

Press contacts :
Annie-Florence Loyer – (0)6 88 20 35 59 – afloyer@newcap.fr
Juliette Milleret – jmilleret@newcap.fr – (0)6 62 41 47 42

Leave a Comment